Skip to main content
BCO logo

BCO · Brinks Co

Track BCO — free
Market Cap
$4.48B
Shares
41.19M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$107.05 Open$106.41 Day$105.70–107.62 52W close$92.16–135.58 Avg vol 30d422K Short int4.8M · 11.7% float · 13.5d Short vol78% Last earningsAug 5, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 6 wks
filed Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.48B
Trailing 12 months
Net income (TTM)
$178.60M
Trailing 12 months
Revenue growth YoY
+7.1%
Year over year
Operating margin
10.5%
Trailing 12 months
P / E (TTM)
24.6
Trailing earnings · reciprocal yield 4.1%
FCF yield
8.8%
TTM · current market cap
Return on invested capital
11.8%
Trailing 12 months
Net cash
−$2.58B
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
-2.1%
Year over year · fewer shares
Price change (1Y)
-7.7%
Trailing year
Short interest
11.7%
Latest settlement · 13.5 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Brink's delivered strong Q2 2026 results with 14% AMS/DRS organic growth (14th consecutive quarter of mid-teens+) and record Q2 EBITDA margins of 18.5%, prompting raised full-year profit expectations. The NCR Atleos acquisition timeline accelerated to early Q1 2027, with regulatory clearances progressing across key jurisdictions.

Bullish
  • + AMS/DRS organic revenue grew 14%, marking the 14th consecutive quarter of mid-teens or better organic growth, more than doubling total revenue to over $1.5 billion.
  • + Record Q2 EBITDA margin of 18.5%, up 70 bps year-over-year with expansion across all operating segments.
  • + Full-year profit expectations raised as EBITDA came in above the midpoint of prior guidance.
  • + Trailing 12-month free cash flow up $32 million to $468 million with 46% EBITDA conversion, above full-year framework.
Bearish
  • FX benefit for full year 2026 narrowed to between 1.5% and 2.5%, less than prior quarter expectations.
  • Organic revenue growth in North America, Latin America, and Europe each decelerated to approximately 2% in the quarter.
  • Argentina austerity measures continue to depress consumption, creating a regional headwind.
  • NCR Atleos acquisition and transformation initiatives drove $75.3 million of expenses in H1 2026, materially impacting GAAP earnings.
  • Pending NCR Atleos acquisition will temporarily push net leverage above 3x at close, with current leverage at 2.7x.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 14.9 · calm Equity put/call 0.53
Technical
price trend
Neutral
50 / 200-day cross Golden cross
Price vs 200-day avg −5%
below
Price vs 50-day avg −5%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 34%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −4%
trailing
6-month return +7%
trailing
YTD return −8%
this year
Relative strength −16%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Golden cross
50d $113 › 200d $113 — 50d above 200d
Institutional flow Distributing
-3% holders QoQ · +45 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
11.72% of float · ▲ +1.5% MoM · 13.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
360 holders — near 3-yr high, broad support
Squeeze score 73
high risk · 0–100
Fundamentals
Strong
Revenue growth −6%
Y/Y
EPS growth +29%
Y/Y
Free cash flow $276.8M
Valuation P/E 25.2
in line
Buyback $720.0M
remaining
Balance sheet $2.3B
net debt
Quant / Vol
risk profile
Moderate
Volatility 33%
annualized · 1-yr
Max drawdown −32%
past year
ATR 3.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 3
Latest guidance · from the 8-K filed Aug 5, 2026
Q3 2026
Non-GAAP EPS Non-GAAP Initiated $2.23 – $2.63
2026 Non-GAAP Framework
Free Cash Flow Conversion Non-GAAP 40% – 45%
Third Quarter 2026
Organic Growth Non-GAAP Initiated 4% – 7%
Total Growth Initiated 2% – 6%
Prior guidance period ended · from the 8-K filed Aug 7, 2024
Adjusted EBITDA margin · 2024 Non-GAAP Outlook 18.4% – 18.9%
EPS from continuing operations attributable to Brink's · 2024 Non-GAAP Outlook $7.30 – $8.00
Adjusted EBITDA · 2024 $935M – $985M
Free cash flow · 2024 $415M – $465M
Guided vs delivered · last 3 settled
Revenue full year 2021
guided $4.1B – $4.2B
$4.2B Beat +1.2%
Free cash flow per share full year 2022
guided $7.00 – $8.00
$3.57 Miss −52.4%
Revenue 2020
guided $3.3B – $3.6B
$3.69B Beat +7.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
Golden cross Bullish
Price vs 200-day avg
−5% Neutral
Price vs 50-day avg
−5% Bearish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
34% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) Golden cross
50d $113 › 200d $113 — 50d above 200d
Institutional flow Distributing
-3% holders QoQ · +45 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
11.72% of float · ▲ +1.5% MoM · 13.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
360 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $92 Now $107 · 34% Range high $136
vs 200-day avg -5% vs 50-day avg -5% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Security & Protection Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BCO
Brinks Co
this stock
$4.48B -8.3% -5.7% 25.2 11.7%
ALLE
Allegion plc
$12.92B -4.9% +7.6% 19.9 4.7%
MSA
MSA Safety Inc
$6.93B +10.7% +3.7% 22.4 2.1%
ADT
ADT Inc.
$5.04B -18.0% +4.7% 3.5%
GEO
Geo Group Inc
$4.23B +87.7% +3.9% 15.2 8.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
360
% held
112.3%
Net QoQ
+5.0M sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
424
View
Short & Settlement
Short Interest Rising
Shares short
4.8M
Days to cover
13.5d
Change
+70.6K sh
View
Short Volume
Short vol %
78%
As of
Sep 21, 2026
Short Total
View
Fails to Deliver
FTD shares
13.5K
Value
$1.5M
As of
Aug 25, 2026
View
Off-Exchange
Off-exchange %
39.2%
Week of
Aug 17, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 31, 2025
View
Financials
Financials
Revenue (FY)
$5.3B
Net income (FY)
$199.7M
EPS diluted
$4.69
View
Buybacks
Authorized
$750.0M
Remaining
$720.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 5, 2026
This year
16
View
Proposed Sales
Value
$2.4M
Shares
21.7K
Filed
Aug 15, 2025
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
BCO -2.0% -3.9% +6.5% -1.7% -8.3%
SPY +1.7% +1.0% +22.4% +0.8% +13.4%
vs SPY -3.7% -5.0% -15.9% -2.6% -21.7%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$750.00M
Spent (derived)
$30.00M
Remaining
$720.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 78890 CUSIP 109696104 13F (30d) 8 filings 8 filers Visit website Investor relations